Evidence map›Paper›PMID 30182521›Full record

ArticleAngewandte Chemie (International ed. in English)2018

Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling.

Weidong Xu, Peng Yin, Mingjie Dai

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weidong XuWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, 02115, USA.ORCID 0000-0002-9457-1036
Peng YinWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, 02115, USA.
Mingjie DaiWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, 02115, USA.ORCID 0000-0002-8665-4966

Funding

Super-resolution imaging via programmable autonomous blinkingR01EB018659 · NIBIB · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2013 to 2017
$3.3M
Engineering Bioimaging Probes Based on Triggered Molecular GeometryDP2OD007292 · OD · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2010 to 2010
$2.5M
Programmable metafluorophores for quantitative multiplex in situ imaging of mRNAR21HD072481 · NICHD · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2012 to 2013
$452k
NIBIB NIH HHS R01 EB018659NICHD NIH HHS R21 HD072481NIH HHS 1DP2OD007292NIH HHS 1R01EB018659NIH HHS 5R21HD072481NIH HHS DP2 OD007292
6 · The paper itself

Abstract

MicroRNA (miRNA) expression profiles hold promise as biomarkers for diagnostics and prognosis of complex diseases. Herein, we report a super-resolution fluorescence imaging-based digital profiling method for specific, sensitive, and multiplexed detection of miRNAs. In particular, we applied the DNA-PAINT (point accumulation for imaging in nanoscale topography) method to implement a super-resolution geometric barcoding scheme for multiplexed single-molecule miRNA capture and digital counting. Using synthetic DNA nanostructures as a programmable miRNA capture nano-array, we demonstrated high-specificity (single nucleotide mismatch discrimination), multiplexed (8-plex, 2 panels), and sensitive measurements on synthetic miRNA samples, as well as applied one 8-plex panel to measure endogenous miRNAs levels in total RNA extract from HeLa cells.

Indexed as

Molecular TypingHeLa CellsHumansMicroRNAsOptical ImagingRNA ProbesMicroRNAsRNA ProbesDNA nanotechnologyDNA-PAINTmicroRNAmultiplexingsuper-resolution imaging

Identifiers

PMID30182521
PMCPMC6314842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.